Atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma

Saved in:
Bibliographic Details
Published inThe lancet oncology Vol. 21; no. 9; p. e412
Main Authors Yang†, Xu, Wang†, Dongxu, Lin, Jianzhen, Yang, Xiaobo, Zhao, Haitao
Format Journal Article
LanguageEnglish
Published London Elsevier Ltd 01.09.2020
Elsevier Limited
Subjects
Bevacizumab
Hepatocellular carcinoma
Liver cancer
Monoclonal antibodies
Targeted cancer therapy
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:1470-2045
1474-5488
DOI:10.1016/S1470-2045(20)30430-7